Paving the Way to New Treatments for Skin Cancer
Skin cancer is the most common type of cancer in the Unites States. Each year, more than 3.5 million cases of skin cancer are diagnosed, that’s one in five Americans who will develop some form of the disease throughout their lifetime. Like all cancers, early detection of melanoma is critical. If caught early, the five-year survival rate is 98 percent.
Our comprehensive care includes the latest investigational treatments for melanoma backed by our world-renowned research investigators. Our cutaneous physicians solely focus on skin cancer and are pioneers in developing and defining the role of lymphatic mapping and sentinel node biopsy for staging of patients with clinically negative nodes, as well as investigating therapies for both node-negative and node-positive patients.
For tips to protect your skin against Melanoma and other skin cancers, click here.
If you or a loved one has a concern or has been recently diagnosed, call 1-888-MOFFITT, or complete a new patient registration form. Remember, you do not need to have a referral to make an appointment at Moffitt Cancer Center.